Even though little research has been done on specific proteins like p53, Mdm2, and Pirh2, a deeper understanding of the protein-protein interaction network offers crucial insights into putative druggable hot spots, facilitating the development of novel modulators for therapeutic interventions against cancer (Daver et al., 2023). Here, MDM2 is linked to cancer.